Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Sun, Yu, Campisi, Judith, Higano, Celestia, Beer, Tomasz M, Porter, Peggy, Coleman, Ilsa, True, Lawrence, Nelson, Peter S·2012·Nature Medicine

Cited by (791)

Items 701–791 of 791

  1. TMErisk score: A tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma
    Yu Li, Xiaozhou Pan, Wenwei Luo, Yaser Gamalla, Zhan Ma, Pei Zhou, Chunfu Dai, Dingding Han · 2024 · Heliyon
  2. Contradictory Relationships between Cancer and Normal Cells and Implications for Anti-cancer Therapy
    Xingchun Gou, Derek Kai Kong, Xu Tang · 2015 · Asian Pacific Journal of Cancer Prevention
  3. The Complexity of Colorectal Cancer Biology — Putting Bricks on the Path to Personalized Medicine
    Emilia Balboa, Ángel Carracedo, Francisco Barros · 2014 · InTech eBooks
  4. Development and Characterization of Mitoxantrone-Loaded Glutaraldehyde Crosslinked Sodium Alginate Nanoparticles for the Delivery of Anticancer Drugs
    Muhammad Wahab Amjad, Maria Abdul Ghafoor Raja · 2021 · Journal of Pharmaceutical Research International
  5. Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials
    Tanzeel Ur Rehman, Kaitlin M. Bratlie · 2021 · Journal of drug targeting
  6. Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials
    Tanzeel Ur Rehman, Kaitlin M. Bratlie · 2021 · Iowa State University Digital Repository (Iowa State University)
  7. Therapeutic Targetingof the Wnt Signaling Network
    Felicity Rudge, Trevor C. Dale · 2014 · Wiley eBooks
  8. Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer via FGF2/ERG/Akt/mTOR Signaling Pathway
    Wenhao Zhou, Yiming Su, Yu Zhang, Bangmin Han, Haitao Liu, Xiaohai Wang · 2020
  9. Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells
    Haissa Oliveira Brito, José de Ribamar Rodrigues Calixto, Rui Medeiros, Rui M. Gil da Costa · 2021 · Translational Oncology
  10. Identification of Cell Nonautonomous DNA Damage Responses in the Tumor Microenvironment that Contribute to Cancer Therapy Resistance
    Ryan R. Gordon · 2013
  11. The Role of Trop2 Cleavage Products in Prostate Tumorigenesis
    Tanya Ivanova Stoyanova · 2013
  12. Editorial Comment from Dr Wu to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer
    Boyang Jason Wu · 2015 · International Journal of Urology
  13. ROLE OF CXCL1 SIGNALING IN STROMA: EPITHELIUM INTERACTIONS DURING BREAST CANCER PROGRESSION
    An Zou · 2014 · KU ScholarWorks (The University of Kansas)
  14. Antitumor Activity of Py-Im polyamides
    Fei Yang · 2014
  15. Leveraging the species barrier to advance cancer therapy
    Song Zhao, Peter S. Nelson · 2013 · Nature Genetics
  16. Tierra, sol, agua y aire: aplicaciones terapéuticas en el paciente oncológico
    Pablo Saz Peiró, Shila Saz Tejero, Grado Fisioterapeuta · 2014 · Dialnet (Universidad de la Rioja)
  17. Identification and Targeting of Candidate Pre-Existing Lurker Cells that Give Rise to Castration-Resistant Prostate Cancer
    Andrew S. Goldstein · 2014
  18. Emerging strategies for therapeutic targeting of the tumour microenvironment
    Xhian M. Quah, RMax Conway, Michele C. Madigan, Richard J. Epstein · 2014 · Cancer Forum
  19. Chapter 1 Prostate Cancer: An Introduction
    L. Manendra Babu, Yadu Vijayan, Kuzhuvelil B. Harikumar · 2016 · Traditional herbal medicines for modern times
  20. Epithelial‐to‐Mesenchymal Transition (EMT): Clinical Implications
    Elisa C. Woodhouse, Suresh Mohla · 2017
  21. Histopathological Evaluation in Prostate Cancer
    Funda Vakar‐Lopez · 2017 · Springer eBooks
  22. The novel roles of stromal fibroblasts in metronomic chemotherapy: Focusing on cancer stemness and immunity
    Wen‐Ying Liao, Tze‐Sian Chan, Kelvin K. Tsai · 2017 · Journal of Cancer Research and Practice
  23. Competition for Resources and Space Contributes to the Emergence of Drug Resistance in Cancer
    Peter Rashkov · 2017 · Studies in computational intelligence
  24. Peking University - Juntendo University Joint Symposium on Cancer Research and Treatment
    Akira Orimo · 2017 · Juntendō Igaku/Juntendo igaku
  25. Microenvironmental Regulation of Tumor Resistance to Anti-IGF-1R Monoclonal Antibody
    이지선 · 2017 · Seoul National University Open Repository (Seoul National University)
  26. Development of a Mathematical Model to Understand, Design & Improve Oncolytic Virus Therapies
    Cory Batenchuk · 2014 · uO Research (University of Ottawa)
  27. Investigating senescence in cellular plasticity and tissue regeneration
    Birgit Ritschka · 2017 · Repositori digital de la UPF (Universitat Pompeu Fabra)
  28. Tumour-stroma Signalling in Cancer Cell Motility and Metastasis
    Valbona Luga · 2014 · TSpace (University of Toronto)
  29. Convergence of Bioengineering, Orthopaedics and Tumour Biology to Develop and Validate Humanized Rodent Models for Primary Bone Tumour Research
    Ferdinand Wagner · 2018 · Queensland University of Technology
  30. Altering the bilayer motif in ERBB2 HER2 TMD and in ErbB HER TMD dimer causing in vitro and in vivo tumor suppression
    Laszlo David Menyhert, Miguel Tejeda · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  31. A influência da Noética na proliferação de células do adenocarcinoma de mama sob quimioterapia
    Tatiana Rocha de Souza · 2018
  32. Ovarian Cancer: Towards Personalizing Ovarian Cancer Treatments Using Patient-Derived Organoids
    Tatiana Volpari, Jacqueline Hebner, Raeka S. Aiyar, Laura A. Martin · 2021 · Elsevier eBooks
  33. TNIK swaths AR to WNT pathway and drives Castration-Resistant Prostate Cancer
    Ning Jiang, Tao Guo, Miaomiao Wang, Yihao Liao, Fuling Ma, Jie Gao, Youzhi Wang, Keke Wang, Yudong Wu, Amilcar Flores‐Morales et al. · 2020
  34. Cancer Microenvironments as Therapeutic Targets
    Sushil Kumar, Lisa M. Coussens · 2014 · Elsevier eBooks
  35. Micro RNA the Important Biomarker in Cancer
    Hiba Sabah Jasim · 2022 · SAR Journal of Medical Biochemistry
  36. The Role of Trop2 Cleavage Products in Prostate Tumorigenesis
    Tanya Ivanova Stoyanova · 2014
  37. Faculty Opinions recommendation of A framework for advancing our understanding of cancer-associated fibroblasts.
    Paul Timpson · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  38. Faculty Opinions recommendation of Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.
    Charlotte Lynne Bevan, Theodora A. Constantin · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  39. Daunorubicin induces Cysteine‐rich protein 61 to decreases the Chemosensitivity through the ATM/NF-κB pathway in B-acute lymphoblastic leukemia
    Pengchong Shi, Zhen Lin, Yanfang Song, Zhaozhong Li, Menglu Zeng, Li Luo, Yingping Cao, Xianjin Zhu · 2022 · Research Square
  40. Senescent cell accumulation & Research-based undergraduate education
    Floris A. Valentijn · 2022
  41. Biopolymer Mediated Macrophage Polarization: A Method of ALS (Amyotropic Lateral Sclerosis) Control
    Ashok K. Chakraborty, Anil R. Diwan · 2022 · Acta Scientific Neurology
  42. Supplementary Materials and Methods from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis
    Xiaohu Zheng, Min Cheng, Binqing Fu, Xiaolei Fan, Qīng Wáng, Xiaoqing Yu, Rui Sun, Zhigang Tian, Haiming Wei · 2023
  43. Data from Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
    Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben, Zhongkai Gu, Joshua W. Russo, David Johnson Einstein, Huihui Ye et al. · 2023
  44. Supplementary Materials and Methods from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis
    Xiaohu Zheng, Min Cheng, Binqing Fu, Xiaolei Fan, Qīng Wáng, Xiaoqing Yu, Rui Sun, Zhigang Tian, Haiming Wei · 2023
  45. Characterization of Novel Canonical WNT Signaling Inhibitors in Prostate and Colorectal Cancers
    Arvinder Singh Jandu · 2013 · UA Campus Repository (The University of Arizona)
  46. Bimodal disruption of the crosstalk between cancer cells and fibroblasts using nanomedicine augments cancer immunotherapy
    Ahmed O. Elzoghby, May S. Freag, Mostafa Mohammed, Arpita Kulkarni, Hagar E. Emam, Krishna Prahlad Maremanda · 2023 · Research Square
  47. Mechanisms of reversal of temozolomide resistance in glioblastoma through downregulation of BCL3 by the Tumor Electric Field Therapy
    Mu-yuan Jia, Yu-yang Liu, Ze Li, Chengke Luo, Shengchao Xu, Huan-Huan Gong, Jianhui Wu, Dan Zhou, Di-kang Chen, Anhua Wu et al. · 2023 · Research Square
  48. A senescence-like state is beneficial for ovarian cancer treatment
    Michael Skulimowski, Llilians Calvo, Shuofei Cheng, Isabelle Clément, Lise Portelance, Yu Zhan, Eurı́dice Carmona, Julie Lafontaine, Manon de Ladurantaye, Kurosh Rahimi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Lymphangiogenesis and Stem Cells in Hematological Malignancies
    Isabel Vidal, Manuel Bernal, Melissa García‐Caballero, Ana R. Quesada, Beatriz Martı́nez-Poveda, Miguel Ángel Medina · 2024 · Elsevier eBooks
  50. The Senescence-Associated Secretory Phenotype: Induction, Regulation, Function and Therapeutic Interventions to Counteract the Negative Effects
    Daniela Frasca · 2024 · Springer eBooks
  51. An in-depth study of DOPE:DOPC liposomes to maximize targeted drug delivery to cancer-associated cells
    Tanzeel Ur Rehman · 2023
  52. Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid Leukemia
    Benjamin J. Rodems, Sonali Sharma, Cameron D. Baker, Christina M. Kaszuba, Takashi Ito, Jane L. Liesveld, Laura Maria Calvi, Michael W. Becker, Craig T. Jordan, John M. Ashton et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Altering the bilayer motif in the ERBB2 HER2 TMD and ErbB HER TMD dimer causing in vitro and in vivo tumor suppression
    Laszlo David Menyhert, Miguel Tejeda · 2025 · Developments in Health Sciences
  54. Predicting miRNA-Drug Interactions Based on Multi-source Feature Fusion of Heterogeneous Network
    Chenyue Lei, Xiujuan Lei, L. Liu, Jianrui Chen, Fang‐Xiang Wu · 2025 · Interdisciplinary Sciences Computational Life Sciences
  55. Genomic landscapes and therapeutic perspectives of cancer stem cells in the tumor microenvironment
    Prabhat Shrestha, Doyoon Lee, Anil Giri, Thu-Huyen Le Thi, Simmyung Yook · 2025 · Journal of Pharmaceutical Investigation
  56. Additional file 1 of The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
    Jurj, Ancuta, Călin Ionescu, Ioana Berindan‐Neagoe, Cornelia Braicu · 2022 · Figshare
  57. Tumor-derived circulating DNA can induce senescence and SASP activation in mouse embryonic fibroblasts
    Ekin Çelik, Ertan Kanbur · 2026 · Biogerontology
  58. ADT and activation of HGF and WNT axes in double-null prostate cancer
    Dexter Hoi Long Leung, Yao Mawulikplimi Adzavon, Gaeul Chu, Tae Ju Park, Kristoffer Nikias, Cheong-Wun Kim, Chenmiao Liu, Zijie Sun · 2026 · Nature Reviews Urology
  59. A differential single-cell transcriptome atlas of left-sided and right-sided colorectal cancer
    Chengzhi Zhao, Weiye Zhou, Guangjian Zeng, Yeen Huang, Chuan Shi, Haibei Ma, Yang Li, Jiachun Lv, Xiaohua Liang, Shenying Fang · 2026 · Discover Oncology
  60. BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation
    Alvin Chen, Dong-Jun Xie, Yu‐Wei Jhu, Yen-Ju Lin, Dong-Yu Wu, Shi-Long Yan, Yu‐Ting Chou, Jen‐Chung Ko · 2026 · Biomedicine & Pharmacotherapy
  61. Metabolic Mayhem in the Tumor Microenvironment: Can Mesenchymal Stromal Cells Restore Order?
    Ahmed M. Abou‐Shanab, Asmaa Khairy, Fatma Hany, Nagwa El‐Badri · 2026 · Stem cell biology and regenerative medicine
  62. Implications de l'adrénomédulline sécrétée par les fibroblastes associés au cancer dans la croissance tumorale
    Zohra Benyahia · 2016
  63. Skin inflammatory responses in cutaneous melanoma and in the atopic march
    Wenjin Yao · 2018
  64. The role of chemotherapy in fibroblast heterogeneity and immune infiltration in high-grade serous ovarian cancer
    Monika Licaj · 2021 · theses.fr (ABES)
  65. Caractérisation clinique et biologique de l’hyperprogression tumorale lors du blocage de la voie PD-1/PD-L1
    Stéphane Champiat · 2019 · theses.fr (ABES)
  66. Impact de la voie d’import mitochondrial contrôlée par le complexe AIF/CHCHD4 sur la survie des cellules cancéreuses et la réponse aux traitements anticancéreux
    Camille Reinhardt · 2019 · theses.fr (ABES)
  67. Regulation of alternative splicing and polyadenylation by genotoxic anti-cancer agents
    Iris Tanaka · 2019 · theses.fr (ABES)
  68. Analyse des sous-populations lymphocytaires B dans la leucémie lymphoïde chronique et de l'Impact de l'ibrutinib sur ces sous-populations
    Anne Quinquenel · 2018 · theses.fr (ABES)
  69. Etude de la dissémination du cancer colorectal
    Guillaume Belthier · 2020 · theses.fr (ABES)
  70. An RNA Signature Links Oxidative Stress To Cellular Senescence
    Nowsheen Mullani · 2019 · theses.fr (ABES)
  71. Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas
    Angélique Vienot · 2021 · theses.fr (ABES)
  72. Cancer associated fibroblasts stimulate cancer resistance to therapy
    Olivier Zajac · 2024
  73. Senescent endothelial cell-derived extracellular vesicles promote neoadjuvant chemoresistance in colorectal cancer via GPX4
    Kunpeng Jia, Yuxin Ding, Menglei Jin, Qi Yang, Xinyu Wang, Yujie Yan, Jiao Xiang, Ruoqi Zhang, Jun Fang, Jingxin Jiang et al. · 2026 · Communications Biology
  74. Pathway-informed Universal Domain Adaptation for Single-cell RNA-seq Data
    Xinrong Wei, Xingyi Li, Huan Liu, Gaoyuan Du, Feng Wei, Xuequn Shang · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of ‘‐mabs’?
    Giuseppe Schepisi, Irene Torresan, Emilio Francesco Giunta, Sara Bleve, Nicole Brighi, Elisa Tassinari, Sofia Zanuccoli, Maria Concetta Cursano, Cristian Lolli · 2026 · The Journal of Pathology
  76. Metabolic Reprogramming in the Bladder Cancer Microenvironment: Bridging Fundamental Research and Therapeutic Avenues for Cancer-Associated Fibroblasts
    Ana Claudia Rodrigues da Silva, Fátima Baltazar, Julieta Afonso · 2026 · Advances in experimental medicine and biology
  77. Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells
    Ryuta Watanabe, Mami Chosei, Haruna Arai, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika · 2026 · Frontiers in Oncology
  78. Advances in Engineered Nano-sensitizers for Chemoradiotherapy of Cancer: Overcoming Microenvironmental Barriers
    Ziyan Zheng, Dan-Hua Zhou, Zhi-Hua Gan, Qing-Song Yu · 2026 · Chinese Journal of Polymer Science
  79. Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications
    Qiuyang Zhang, Keyi Shen, Sen Liu · 2026 · Cells
  80. Histone erasers in prostate cancer: Clearing the path for progression & therapy resistance
    Buse Cevatemre, İpek Bulut, Neslihan Yuksel-Catal, Ezgi Karyemez, Deniz Yildiz, Ceyda Açılan · 2026 · Critical Reviews in Oncology/Hematology
  81. Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy
    Ertan Kanbur, Ömer Faruk Aydin · 2026 · Biogerontology
  82. A Review of Senescence‐Associated Secretory Phenotype‐Mediated Remodeling of the Tumor Microenvironment: Implications for Cancer Progression and Therapy
    Sneha Pallatt, Sibin Nambidi, Antara Banerjee, Surajit Pathak · 2026 · Cancer Reports
  83. Therapy-educated fibroblast states link treatment pressure to residual disease and acquired resistance in gastric cancer
    Zhigang Chen, Yongtao Yang, Ting Yang, Liping Gao, Ting Zhou, Mengyu Deng · 2026 · Frontiers in Immunology
  84. Mechanism and therapeutic prospects of ferroptosis regulation through m6A in cancer
    Yushuo Duan, Ziyi Xu, Jiahao Liang, Ruile Shen, Penghui Li · 2026 · Frontiers in Cell and Developmental Biology
  85. Cancer-associated fibroblasts during and after therapy: disentangling state, function and persistence
    Hongpeng Guo, Chenglin Sun · 2026 · Cancer Treatment and Research Communications
  86. Reframing cancer therapy through tumor plasticity
    Akansha M. Shah, Bryan Marsh, Frédéric J. de Sauvage · 2026 · Nature Cancer
  87. Residual disease as a therapy-remodeled ecosystem: spatial niches, tumor persistence, and relapse in solid tumors
    Nataša Prvulović Bunović, Olivera Ivanov, Saima Korać, Nikola Denda, Ivana Majkić, Nemanja Maletin · 2026 · Frontiers in Oncology
  88. Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential
    Liting Zhou, Mengyue Tang, Keke Wang, Nan Wang, Jiachen Zhang, Kangdong Liu, Xiang Li, Zigang Dong · 2026 · Signal Transduction and Targeted Therapy
  89. Resistance to Castration – Resistance to Drugs
    Stefania Staibano · 2013 · Springer eBooks
  90. Consequences of cell death in the model organism Drosophila melanogaster: potential implications for cancer treatments
    Angela Delano · 2015 · CU Scholar (University of Colorado Boulder)
  91. Vitamin D receptor activity is differentially affected by the co-regulator Hic-5 in prostate cancer and stromal cells
    Joshua D. Solomon · 2013